PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Repurposed radiotracer lights up treatment-resistant tumors 'like a Christmas tree'
Use of the new tracer could improve outcomes by enabling providers to adjust treatment regimens much earlier than they have been able to previously.
Global shortage of nuclear imaging isotopes may be over
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
Researchers receive grant worth millions to develop portable PET scanner
Experts are hopeful that the portable scanner could improve access to neuroimaging used in the diagnosis and monitoring of Alzheimer's disease.
Understanding hospital billing for cardiac PET/CT
Significant fluctuations in PET and CT reimbursement rates have made it especially challenging to keep up with this complex topic. We spoke to an expert to learn more.
Lizard saliva could be key to spotting elusive pancreatic tumors
By binding the substance to a radiotracer, experts were able to improve the accuracy of identifying these tumors by as much as 30% compared to the standard of care.

ASNC 2023 president calls for nuclear cardiology to embrace new technology

American Society of Nuclear Cardiology (ASNC) 2023 President Mouaz H. Al-Mallah, MD, said the subspecialty needs to up its game with new technology.

January 3, 2023

Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

Why clinicians should know if patients are on the keto diet before undergoing PET imaging

Patients adhering to a ketogenic diet can show reduced cerebral 18F-FDG uptake on PET imaging, study shows.

December 21, 2022

CMS cites 'newly published evidence' in postponement of PET coverage decision

Prior to the Dec. 15 announcement, CMS had released a different statement in June informing the public that they were reconsidering the amount of PET scans that Alzheimer’s patients undergoing monoclonal antibody treatment can receive.

December 19, 2022

New radiotracer IDs numerous cancers likely to respond to targeted therapy

The radiotracer, 68Ga-PentixaFor, can be used for detecting C-X-C motif chemokine receptor 4 (CXCR4), which plays a significant role in cancer progression.

December 8, 2022

Cognitive decline not far behind amyloid and tau PET-positive scans, even for the asymptomatic

Common markers of Alzheimer's disease visualized on PET scans of asymptomatic patients might foreshadow the onset of symptoms in the years following their initial discovery.

December 7, 2022

FDG PET/CT spots COVID-induced pancreatitis

There are limited data to determine whether pancreatitis in COVID patients is the result of a stress response triggered by severe illness or by direct damage to the β-cell structure and function.

November 22, 2022